Aurobindo Pharma Gets US FDA Approval for Perampanel Tablets
Aurobindo Pharma has received US FDA final approval for Perampanel Tablets, 2 mg to 12 mg, equivalent to Fycompa Tablets.
Epilepsy Treatment | 06/10/2026 | By News Bureau | 186
Ono Pharmaceuticals Gets Nod for XCOPRI Tablets in Japan
Ono has received manufacturing and marketing approval in Japan for XCOPRI tablets to treat partial-onset seizures, with or without secondary generalisation.
Epilepsy Treatment | 18/09/2026 | By News Bureau | 122
Alkem Launches NeuCeno (Cenobamate) Treatment of Partial-onset Seizures in Adult Patients
Alkem launches NeuCeno (cenobamate) in India for partial-onset seizures in adults, marking the first introduction of cenobamate in the country.
Epilepsy Treatment | 16/09/2026 | By News Bureau
Akums Highlights Lacosamide's Versatility in Epilepsy Management
Akums Drugs & Pharmaceuticals reaffirmed lacosamide, a well-established antiepileptic drug (AED), as a versatile and effective option for patients with epilepsy across age groups and clinical settings.
Epilepsy Treatment | 22/09/2025 | By Dineshwori | 262
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy